1Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey
2Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey
S Ugurlu
Volume 35, Issue 1, March 2024
Sign in to download the Issue in PDF format.
1712873600
Mediterr J Rheumatol 2022;33(2):237-40
Article Links
Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders
Abstract
This paper has no abstract.Cite this article as: Alkan A, Ugurlu S. Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders. Mediterr J Rheumatol 2022;33(2):237-40.
Article Submitted: 8 Feb 2021; Revised Form: 1 Sep 2021; Article Accepted: 30 Sep 2021; Available Online: 30 Jun 2022
https://doi.org/10.31138/mjr.33.2.237
This work is licensed under a Creative Commons Attribution 4.0 International License.
©Alkan A, Ugurlu S.
